The dual endothelin receptor antagonist, bosentan, is an orally active therapy, which has
been proved to be effective in the treatment of pulmonary arterial hypertension (PAH). This …

Pulmonary arterial hypertension (PAH), which can be a complication of human
immunodeficiency virus (HIV) infection, is characterized by increased pulmonary arterial …

A Hipertensão Pulmonar (HP) era, até há bem pouco tempo, uma entidade obscura,
frequentemente não identificada, porque omissa nos processos comuns de diagnóstico e …

The management of paediatric patients with pulmonary hypertension are mostly based on
reports on adult patients. There is a long felt need to establish guidelines which are relevant …

Im Februar 2008 fand in Dana Point, Kalifornien, das „4th World Symposium on Pulmonary
Hypertension “statt, im Rahmen dessen internationale Experten über die neuesten …

A Hipertensão Pulmonar (HP) era, até há bem pouco tempo, uma entidade obscura,
frequentemente não identificada, porque omissa nos processos comuns de diagnóstico e …

Pulmonary vascular disease (PVD) summarizes all congenital or acquired pathologies that
affect the pulmonary vasculature. One of these is pulmonary hypertension (PH), which is …

The stimuli that can trigger the initiation of changes in the pulmonary vasculature can be a
systemic disorder (ie connective tissue disease [CTD]), environmental changes (ie hypoxia) …

Pulmonary hypertension (PH) is an increase in pulmonary artery pressure in the pulmonary
vascular bed that ultimately may lead to progressive right heart strain and ultimately, right …

A Hipertensão Pulmonar (HP) era, até há bem pouco tempo, uma entidade obscura,
frequentemente não identificada, porque omissa nos processos comuns de diagnóstico e …